Paper

Meta-analysis of efficacy of quinine for treatment of nocturnal leg cramps in elderly people

BMJ 1995; 310 doi: 10.1136/bmj.310.6971.13 (Published 7 January 1995)
Cite this as: BMJ 1995;310:13
  1. Malcolm Man-Son-Hing, assistant professor of medicinea,
  2. George Wells, associate professorb
  1. a Division of Geriatric Medicine, University of Ottawa, Geriatric Assessment Unit, Ottawa Civic Hospital, Ottawa, Ontario, Canada K1Y 4E9
  2. b Department of Medicine, University of Ottawa, Clinical Epidemiology Unit, Ottawa Civic Hospital, Ottawa, Ontario, Canada
  1. Correspondence to: Dr Man-Son-Hing.
  • Accepted 4 November 1994

Abstract

Objective: To assess quantitatively the efficacy of quinine (as quinine sulphate) compared with placebo in the treatment of nocturnal leg cramps.

Design: A meta-analysis of six randomised, double blind, crossover trials.

Setting: Randomised trials that were available as of April 1994.

Subjects: A total of 107 general ambulatory patients who suffered from regular nocturnal leg cramps from six clinical trials.

Results: Data from individual patients were used to calculate point estimates and 95% confidence intervals for each of the outcome measures reported by these studies. Treatment with quinine resulted in a significant reduction in the number of cramps for a four week period compared with placebo (8.83 fewer cramps; 95% confidence interval 4.16 to 13.49). Treatment with quinine reduced the number of nights with cramps by 27.4% (24.0% to 30.8%) compared with placebo. Treatment did not produce a significant change in the severity or duration of individual nocturnal leg cramps. Side effects were uncommon.

Conclusions: The results indicate that quinine can prevent nocturnal leg cramps in general ambulatory populations. Given the possible serious side effects of treatment with quinine, the benefits and risks in patients taking this drug should be closely monitored.

Key messages

  • Key messages

  • The results of this meta-analysis show that quinine sulphate is more effective than placebo in reducing the number of cramps experienced by patients

  • This analysis also suggests that dosing is cumulative, therefore a trial of at least four weeks of quinine may be necessary to show a beneficial effect

  • Quinine should be taken on a regular as opposed to as needed basis as it could not be shown definitively to reduce the severity or duration of an individual cramp

Footnotes

    • Accepted 4 November 1994

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular